Nine European Hospitals Receive Awards in Rome

HIMSS EuropeThe analytics unit of HIMSS Europe awarded nine European hospitals with a Stage 6 Award during an awards ceremony at the annual CIO Summit, taking place in Rome from 6 - 7 October.

The awarded hospitals are: Galway Clinic with 146 beds, Azienda Ospedaliera of Vimercate with 527 beds, Zaans Medisch Centrum with 290 beds, Izmir Tire Devlet Hastanesi with 232 beds, Rize Devlet Hastanesi, Rize with 293 beds, Mersin Erdemli Devlet Hastanesi with 159 beds, Bursa Dörtçelik Hastanesi with 350 beds, Croydon University Hospital with 518 beds and Polyclinique de la Clarence with 205 beds.

It is the first time that hospitals in the UK and Ireland receive an EMRAM Stage 6 Award. There are now three Stage 6 hospitals in Italy, nine in France, eleven in the Netherlands and five in Turkey. In total there are fifty-two (52) hospitals in Europe recognized with the Stage 6, and two hospitals with the Stage 7, one in Germany and one in Spain.

The European EMR Adoption Model (EMRAM) has been adapted to meet the unique needs of European Healthcare Institutions as a methodology for evaluating the progress and impact of electronic medical record systems in hospitals. Tracking their progress in completing eight stages (0‐7), hospitals can review the implementation and utilization of information technology applications with the intent of reaching Stage 7, which represents a superior electronic patient record environment.

Stage 6 & 7 hospitals provide best practices that other healthcare organizations can study as they strive to use EMR applications to improve patient safety, clinical outcomes and patient care delivery efficiency.

Rainer Herzog, Managing Director, HIMSS Europe "At this year's CIO Summit we are happy to award not only the largest number of Stage 6 hospitals to date, but also hospitals from a range of countries, including two "newcomers" - Ireland and UK. Especially noteworthy is that four of eight award recipients are from Turkey, which reflects the great commitment of the Turkish health authorities to embracing new technologies for the betterment of healthcare."

About HIMSS Analytics
The analytics unit of HIMSS Europe provides health care organisations, governments and industry with extensive data resources and services about the adoption and use of healthcare information technology in Europe. Offerings include comparative Hospital IT adoption benchmarking, a European‐formulated EMR Adoption Model (EMRAM) scale, and other resources to help hospital directors, IT executives and clinicians compare and measure their progress and how they compare to others. Country level and application specific reports also provide insights into major IT adoption trends and applications.

About HIMSS
HIMSS is a global, cause-based, not-for-profit organization focused on better health through information technology (IT). HIMSS leads efforts to optimize health engagements and care outcomes using information technology.

HIMSS is a part of HIMSS WorldWide, a cause-based, global enterprise producing health IT thought leadership, education, events, market research and media services around the world. Founded in 1961, HIMSS WorldWide encompasses more than 52,000 individuals, of which more than two-thirds work in healthcare provider, governmental and not-for-profit organizations across the globe, plus over 600 corporations and 250 not-for-profit partner organizations, that share this cause. HIMSS WorldWide, headquartered in Chicago, serves the global health IT community with additional offices in the United States, Europe, and Asia.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...